glp-1 news today 2025 november Patients Face New Barriers for GLP-1 Drugs ISPOR 2025: Exploring reasons for
Description
GLP-1, released in response to food intake, signals the brain to reduce appetite and increase satiety
From the very first week, I noticed a major difference in how I felt throughout the daymy appetite was under control, my cravings dropped, and I wasnt constantly thinking about food
Nevertheless, GLP-1RA therapy is associated with a pattern of adverse events affecting their safety and tolerability
By month three, a clear separation emerges, with compounded users demonstrating significantly lower continuation rates
46.5% and 66.2%, respectively)
When you eat less, you simply have less room for error
